• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Gut Microbes . Gut microbiota from patients with COVID-19 cause alterations in mice that resemble post-COVID symptoms

tetano

Editor, Senior Moderator
Gut Microbes


. 2023 Dec;15(2):2249146.
doi: 10.1080/19490976.2023.2249146. Gut microbiota from patients with COVID-19 cause alterations in mice that resemble post-COVID symptoms

Viviani Mendes de Almeida[SUP] 1 [/SUP], Daiane F Engel[SUP] 2 [/SUP], Mayra F Ricci[SUP] 1 [/SUP], Clênio Silva Cruz[SUP] 1 [/SUP], Ícaro Santos Lopes[SUP] 3 [/SUP], Daniele Almeida Alves[SUP] 4 [/SUP], Mirna d' Auriol[SUP] 5 [/SUP], João Magalhães[SUP] 1 [/SUP], Elayne C Machado[SUP] 1 [/SUP], Victor M Rocha[SUP] 1 [/SUP], Toniana G Carvalho[SUP] 6 [/SUP], Larisse S B Lacerda[SUP] 7 [/SUP], Jordane C Pimenta[SUP] 7 [/SUP], Mariana Aganetti[SUP] 1 [/SUP], Giuliana S Zuccoli[SUP] 8 [/SUP], Bradley J Smith[SUP] 8 [/SUP], Victor C Carregari[SUP] 8 [/SUP], Erika da Silva Rosa[SUP] 1 [/SUP], Izabela Galvão[SUP] 1 [/SUP], Geovanni Dantas Cassali[SUP] 9 [/SUP], Cristiana C Garcia[SUP] 10 [/SUP], Mauro Martins Teixeira[SUP] 7 [/SUP], Leiliane C André[SUP] 5 [/SUP], Fabiola Mara Ribeiro[SUP] 6 [/SUP], Flaviano S Martins[SUP] 11 [/SUP], Rafael Simone Saia[SUP] 12 [/SUP], Vivian Vasconcelos Costa[SUP] 7 [/SUP], Daniel Martins-de-Souza[SUP] 8 13 14 15 [/SUP], Philip M Hansbro[SUP] 16 [/SUP], João Trindade Marques[SUP] 4 17 [/SUP], Eric R G R Aguiar[SUP] 3 [/SUP], Angélica T Vieira[SUP] 1 [/SUP]



Affiliations
Abstract

Long-term sequelae of coronavirus disease (COVID)-19 are frequent and of major concern. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection affects the host gut microbiota, which is linked to disease severity in patients with COVID-19. Here, we report that the gut microbiota of post-COVID subjects had a remarkable predominance of Enterobacteriaceae strains with an antibiotic-resistant phenotype compared to healthy controls. Additionally, short-chain fatty acid (SCFA) levels were reduced in feces. Fecal transplantation from post-COVID subjects to germ-free mice led to lung inflammation and worse outcomes during pulmonary infection by multidrug-resistant Klebsiella pneumoniae. transplanted mice also exhibited poor cognitive performance. Overall, we show prolonged impacts of SARS-CoV-2 infection on the gut microbiota that persist after subjects have cleared the virus. Together, these data demonstrate that the gut microbiota can directly contribute to post-COVID sequelae, suggesting that it may be a potential therapeutic target.

Keywords: COVID-19; SARS-CoV-2; antimicrobial-resistance; inflammation; microbiota; post-COVID.

 
Back
Top Bottom